[Captopril-induced attacks of bronchial asthma]. 1989

M Banaszewski, and T Szajewski, and J Stepińska

There was presented the case of a bronchial asthma attack in 29 years old patient with congestive heart failure and a history of atopic bronchial asthma in 30th minute after 12.5 mg of captopril administration.

UI MeSH Term Description Entries
D008297 Male Males
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

M Banaszewski, and T Szajewski, and J Stepińska
January 1956, International archives of allergy and applied immunology,
M Banaszewski, and T Szajewski, and J Stepińska
January 1970, Anales de cirugia,
M Banaszewski, and T Szajewski, and J Stepińska
January 1953, Annals of allergy,
M Banaszewski, and T Szajewski, and J Stepińska
December 1966, Vrachebnoe delo,
M Banaszewski, and T Szajewski, and J Stepińska
February 1948, Annals of allergy,
M Banaszewski, and T Szajewski, and J Stepińska
June 1975, The New England journal of medicine,
M Banaszewski, and T Szajewski, and J Stepińska
May 1979, Fel'dsher i akusherka,
M Banaszewski, and T Szajewski, and J Stepińska
January 1950, Acta medica Scandinavica. Supplementum,
M Banaszewski, and T Szajewski, and J Stepińska
September 1995, Voenno-meditsinskii zhurnal,
M Banaszewski, and T Szajewski, and J Stepińska
June 1949, Prensa medica argentina,
Copied contents to your clipboard!